He said this during a speech at the Biotechmed forum.
“Pharmaceutical products today do not apply to products prohibited from being supplied to our market,” RIA Novosti quotes him.
Answering the question about the possibility of including pharmaceutical products in the list of parallel imports, she indicated that "today there is no need for this."
Earlier, the head of the Ministry of Industry and Trade said that food products are not planned to be allowed for parallel imports.
On September 19, Manturov, in an interview with Izvestia, said that the volume of parallel imports in 2022 is projected at $20 billion.